Tag Archives: AIR

Cancer Immunotherapy Pilot Program Set to Expire in June Unless Extended

Author: Rachael P. Dippold, Ph.D.
Editor:  Amanda K. Murphy, Ph.D.

Last year, President Obama announced the National Cancer Moonshot, an initiative with the goal of making ten years’ worth of advances in cancer research and treatment over the following five years.  In support of this initiative, the USPTO announced its “Patents 4 Patients” program, also known as the Cancer Immunotherapy Pilot Program.  Through this pilot program, which began June 29, 2016, applications directed to cancer immunotherapy are provided special status for examination, with the goal of completing prosecution within 12 months of the grant of special status.  Continue reading

Tagged , , , , ,

Examining the Examiner Interview

Author: Adriana L. Burgy
Editor:  Michelle Pacholec, Ph.D.

Compact or streamlined prosecution is in vogue in prosecution circles these days.  While examiner interviews are a tried and true “old” tool in a prosecutor’s tool box, they are reemerging as a means to facilitate compact or streamline prosecution, benefiting both clients and the USPTO. Some of the advantages that are driving their popularity include the fact that examiner interviews can reduce prosecution costs, minimize arguments of record, and decrease prosecution time.  Continue reading

Tagged , , , , ,